KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.1830
+0.0052 (2.92%)
At close: Apr 9, 2026, 4:00 PM EDT
0.1832
+0.0002 (0.11%)
After-hours: Apr 9, 2026, 7:49 PM EDT
KALA BIO Employees
KALA BIO had 38 employees as of December 31, 2024. The number of employees decreased by 5 or -11.63% compared to the previous year.
Employees
38
Change (1Y)
-5
Growth (1Y)
-11.63%
Revenue / Employee
n/a
Profits / Employee
-$943,184
Market Cap
5.17M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 38 | -5 | -11.63% |
| Dec 31, 2023 | 43 | 9 | 26.47% |
| Dec 31, 2022 | 34 | -158 | -82.29% |
| Dec 31, 2021 | 192 | 4 | 2.13% |
| Dec 31, 2020 | 188 | 52 | 38.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 57 |
| Jaguar Health | 49 |
| Aptevo Therapeutics | 37 |
| BiomX | 20 |
| Cardio Diagnostics Holdings | 17 |
| Dermata Therapeutics | 8 |
| Artelo Biosciences | 7 |
| Galmed Pharmaceuticals | 6 |
KALA News
- 8 days ago - Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities - GlobeNewsWire
- 10 days ago - KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live - GlobeNewsWire
- 10 days ago - EXCLUSIVE: Penny Stock Kala Bio Transitions To Revenue Model With AI Platform Launch - Benzinga
- 22 days ago - Red Light Holland Engages Kala Bio's Researgency.AI Platform to Support Clinical Development of Filament's Patented PEX010 Botanical Psilocybin Drug Candidate - GlobeNewsWire
- 22 days ago - Red Light Holland Engages Kala Bio's Researgency.ai Platform to Support Clinical Development of Filament Health's Patented PEX010 Botanical Psilocybin Drug Candidate - Newsfile Corp
- 4 weeks ago - Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents - Newsfile Corp
- 4 weeks ago - Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates - GlobeNewsWire
- 4 weeks ago - Stock Trend Capital Provides Younet AI Investment Update - Newsfile Corp